Microarray-based methylation profiling |
Endonuclease restriction-based microarray analysis |
CHARM |
McrBC |
- |
- |
Identify hyper- or hypomethylated CpG sites |
Moderate resolution; limit to restriction enzymes digested sites |
22, 23
|
DMH |
BstUI/HpaII |
- |
- |
10, 11
|
HELP |
HpaII/MspI |
- |
- |
16, 17
|
MCAM |
SmaI/XmaI |
- |
- |
12 |
McrBC |
McrBC |
- |
- |
19, 20
|
MMASS |
McrBC/cocktail |
- |
- |
21 |
PMAD |
HpaII/MspI |
- |
- |
15 |
Bisulfite conversion-based microarray analysis |
MSO |
- |
Yes |
- |
Cost efficiency |
Moderate resolution |
24 |
Bead array |
- |
Yes |
- |
28, 29
|
Affinity-based microarray analysis |
MeDIP |
- |
- |
Yes |
Efficient assays to CGIs and repetitive sequences |
Less sensitive to CpG poor sites |
30 |
MIRA |
- |
- |
Yes |
|
Depending on MBD binding ability |
32-34
|
Sequencing-based methylation profiling |
BS-seq |
- |
Yes |
- |
High resolution |
Higher cost at this stage |
39 |
MethylC-Seq |
- |
Yes |
|
|
|
44, 45
|
RRBS |
MspI |
Yes |
- |
Each sequencing-read contains at least one CpG site |
Limit to restriction enzymes digested sites |
41 |
HELP-seq |
HpaII/MspI |
- |
- |
17 |
Padlock probe |
Could be |
Yes |
- |
Quantify DNA methylation in a smaller genome fraction with high resolution at this stage |
Limit to probes designing |
42, 43
|
MeDIP-seq |
- |
- |
- |
Moderate resolution |
Less sensitive to CpG poor sites |
31 |